• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vitro studies on the duration of action of dihydroergotamine.

作者信息

Müller-Schweinitzer E

出版信息

Int J Clin Pharmacol Ther Toxicol. 1980;18(2):88-91.

PMID:7372380
Abstract

Changes in tension were monitored isometrically on spiral strips from canine saphenous and femoral veins. Dihydroergotamine elicited an increase in tension at threshold concentrations (about 0.1 ng/ml) which are in accordance with mean plasma levels found in vivo after single oral doses in dog and man. In addition, it was demonstrated that the dihydroergotamine-induced venoconstriction persisted for several hours even when the drug was eliminated from the bathing solution.

摘要

相似文献

1
In vitro studies on the duration of action of dihydroergotamine.
Int J Clin Pharmacol Ther Toxicol. 1980;18(2):88-91.
2
On the pharmacology of venous smooth muscle from dog and man.关于狗和人的静脉平滑肌的药理学
Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(5-6):690-704.
3
[Comparative responsiveness of isolated saphenous, femoral and external carotid arteries and veins of dogs to dihydroergotamine mesylate (DEM) (author's transl)].
Nihon Yakurigaku Zasshi. 1981 Sep;78(3):223-30.
4
Ex vivo studies after oral treatment of the beagle with dihydroergotamine.用双氢麦角胺对小猎犬进行口服治疗后的体外研究。
Eur J Pharmacol. 1983 Apr 22;89(1-2):1-8. doi: 10.1016/0014-2999(83)90601-5.
5
Pharmacodynamics and pharmacokinetics of dihydroergotamine (DHE) in conscious beagle dogs.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(1-2):162-5.
6
Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
J Cardiovasc Pharmacol. 1987 Jun;9(6):686-93.
7
[Experimental pharmacological studies of the venous tonus-modifying effect of dihydroergotamine].[二氢麦角胺对静脉张力调节作用的实验药理学研究]
Z Gesamte Inn Med. 1984 Sep 1;39(17):414-7.
8
Proceedings: Further studies on the mode of action of ergotamine on canine vein strips.论文集:关于麦角胺对犬静脉条作用方式的进一步研究。
Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R68.
9
The pharmacokinetics of dihydroergotamine in the beagle.
Int J Clin Pharmacol Biopharm. 1978 Mar;16(3):124-8.
10
What is known about the action of dihydroergotamine on the vasculature in man?关于双氢麦角胺对人体血管系统的作用,人们了解多少?
Int J Clin Pharmacol Ther Toxicol. 1984 Dec;22(12):677-82.

引用本文的文献

1
Why is the therapeutic effect of acute antimigraine drugs delayed? A review of controlled trials and hypotheses about the delay of effect.急性偏头痛治疗药物的疗效为何会延迟?对对照试验的回顾和对疗效延迟的假设。
Br J Clin Pharmacol. 2019 Nov;85(11):2487-2498. doi: 10.1111/bcp.14090. Epub 2019 Sep 4.
2
Contractile Response of Bovine Lateral Saphenous Vein to Ergotamine Tartrate Exposed to Different Concentrations of Molecularly Imprinted Polymer.不同浓度分子印迹聚合物暴露下的麦角新碱对牛外侧隐静脉收缩反应的影响
Toxins (Basel). 2018 Jan 30;10(2):58. doi: 10.3390/toxins10020058.
3
Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine.
发作期缺乏与脑实质的结合表明在硝酸甘油诱发的偏头痛期间,血脑屏障对11C-二氢麦角胺保持完整。
Brain. 2016 Jul;139(Pt 7):1994-2001. doi: 10.1093/brain/aww096. Epub 2016 May 27.
4
What can be learned from the history of recurrence in migraine? A comment.从偏头痛复发史中可以学到什么?一则评论。
J Headache Pain. 2009 Oct;10(5):311-5. doi: 10.1007/s10194-009-0144-0. Epub 2009 Aug 25.
5
The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusion.
Eur J Clin Pharmacol. 1983;24(6):813-8. doi: 10.1007/BF00607093.
6
Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptors.对双氢麦角环肽和双氢麦角胺的静脉收缩反应:5-羟色胺1样受体参与的证据。
Cardiovasc Drugs Ther. 1990 Dec;4(6):1455-60. doi: 10.1007/BF02026491.